Literature DB >> 11811882

Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies.

J F Huang1, S N Lu, P Y Chue, C M Lee, M L Yu, W L Chuang, J H Wang, C Y Dai, I L Chen, C H Shih, W Y Chang.   

Abstract

The aim of the study was to elucidate the epidemiological features of Hepatitis C virus (HCV) infection among teenagers in an endemic area by conducting a mass screening study. We also investigated the clinical outcome of the anti-HCV-positive subjects by conducting subsequent short-term and long-term follow-up studies. All 2837 students of two junior middle schools in Tzukuan, aged 13-16 years, were invited to be screened for anti-HCV, HBsAg, AST and ALT in October 1995. A total of 2726 (96%) students responded. Anti-HCV, HCV RNA and aminotransferase levels were evaluated among anti-HCV-positive students 1 month and 30 months later, respectively. A total of 38 (1.4%; M/F = 22/16) participants were anti-HCV-positive. The anti-HCV-positive students had higher rates of exposures to transfusion, anti-HCV-positive families and surgery. The prevalence (2.8%) of the 7 maritime villages was markedly higher than that (0.7%) of the other 8 villages (P < 0.001). Subsequent follow-up studies demonstrated that there might be 5 cases of acute or recent HCV infection, and 6 cases who had recovered from chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11811882      PMCID: PMC2869774          DOI: 10.1017/s0950268801006148

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

Review 1.  Hepatitis C virus infection in children coinfected with HIV: epidemiology and management.

Authors:  Massimo Resti; Chiara Azzari; Flavia Bortolotti
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

Review 3.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

4.  Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.

Authors:  Ming-Lung Yu; Ming-Lun Yeh; Pei-Chien Tsai; Ching-I Huang; Jee-Fu Huang; Chung-Feng Huang; Meng-Hsuan Hsieh; Po-Cheng Liang; Yi-Hung Lin; Ming-Yen Hsieh; Wen-Yi Lin; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Chia-Yen Dai; Wan-Long Chuang; Wen-Yu Chang
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan.

Authors:  Ying-Chou Huang; Chung-Feng Huang; Shu-Fen Liu; Hung-Yin Liu; Ming-Lun Yeh; Ching-I Huang; Meng-Hsuan Hsieh; Chia-Yen Dai; Shinn-Chern Chen; Ming-Lung Yu; Wan-Long Chuang; Jee-Fu Huang
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

6.  Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan.

Authors:  Pei-Chien Tsai; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Meng-Hsuan Hsieh; Jeng-Fu Yang; Po-Yao Hsu; Po-Cheng Liang; Yi-Hung Lin; Tyng Yuan Jang; Ming-Yen Hsieh; Chia-Yen Dai; Zu-Yau Lin; Shinn-Chern Chen; Jee-Fu Huang; Ming-Lung Yu; Wan-Long Chuang; Wen-Yu Chang
Journal:  BMJ Open       Date:  2021-03-15       Impact factor: 2.692

7.  Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).

Authors:  Jee-Fu Huang; Ming-Yen Hsieh; Yu-Ju Wei; Jen-Yu Hung; Hsuan-Ti Huang; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Tyng-Yuan Jang; Po-Yao Hsu; Po-Cheng Liang; Chia-Yen Dai; Zu-Yau Lin; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 9.029

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.